Tag: AstraZenecas
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough...
A few months ago, AstraZeneca’s Brilinta added a new U.S. indication to reduce the chance of a first heart attack or stroke in certain...
Imfinzi maker AstraZeneca’s ‘Notes’ campaign delivers encouragement to lung cancer patients
Lung cancer diagnosis and treatment are tough enough in the best of times. AstraZeneca’s new campaign aims to help patients going through both, at a...
AstraZeneca’s Farxiga cuts serious events by half in patients with chronic...
AstraZeneca has shaken up the lucrative heart failure market with diabetes med Farxiga after a major approval earlier this year. But in kidney disease, another...
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...
